Part 2 Q&A: Meet the MiraDx Research Team
“We’re pivoting from being focused on the disease to being focused on the patient and providing the tools to personalize each individual’s treatment.” –Mattias
Read More“We’re pivoting from being focused on the disease to being focused on the patient and providing the tools to personalize each individual’s treatment.” –Mattias
Read MoreAs an undergraduate volunteer in Dr. Weidhaas’ laboratory at UCLA, which focuses on the genetics behind cancer, and how it impacts biology—specifically microRNA genetic differences, such as MiraKind’s KRAS-variant, I have an...
Read More